Clearside Biomedical Inc reports results for the quarter ended in March - Earnings Summary

Clearside Biomedical,

11/05/2023 14:32

* Clearside Biomedical Inc  CLSD.OQ  reported a quarterly
adjusted
loss of 15 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 14 cents per share.
    * Revenue fell 98.8% to $4.00 thousand from a year ago;
analysts
expected $144.00 thousand. 
    * Clearside Biomedical Inc's reported EPS for the quarter
was a
loss of 15 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Clearside Biomedical Inc shares had risen by 11.5% this
quarter and gained 3.6% so far this year.
    * The company reported a quarterly loss of $9.28 million.
    * Wall Street's median 12-month price target for Clearside
Biomedical Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.14          -0.15          Missed
 Dec. 31 2022      -0.13          -0.16          Missed
 Sep. 30 2022      -0.03          -0.13          Missed
 Jun. 30 2022      -0.13          -0.13          Met